IVC Filter

fracture, migration, perforation, hemorrhage or tilting
IVC Filter

ABOUT THE DEVICE

Retrievable inferior vena cava filters also known as IVC filters are small, metal devices that are designed to stop blood clots from traveling to the lungs. The device resembles a metal cage. It must be surgically inserted into a patient’s vein by a medical professional. Though most patients take blood thinners to stop blood clots, doctors use IVCs on patients who cannot – for whatever reason - use blood thinners.

The device was introduced in 1979, and its use increased through the years. By 2012, doctors inserted over 259,000 IVC filters in patients.

PURPOSE OF THE DEVICE

The inferior vena cava is the largest vein in the body, moving deoxygenated blood from the lower legs to the heart and then the lungs. In order to prevent life-threatening pulmonary embolisms (PEs), blood clots from traveling through the vein into the lungs, doctors implant an IVC filter in the vein. Retrievable filters are associated with potential risks, like damaging veins and failing to stop blood clots from bypassing the device.

A doctor will insert the device into a patient’s inferior vena cava using a catheter via a small incision in the neck or groin. The device’s metal wires then capture and trap blood clots before they can reach the lungs.

Some filters are permanent, and some are retrievable or temporary. Doctors remove retrievable filters in a similar way as they implant them. Healthcare providers inject contrast or X-ray dye around the device to make sure it is safe to proceed with the removal. A catheter-like snare goes into the vein and grabs the hook located at the end of the filter. The filter is then covered by a sheath and pulled out of the vein.

WARNINGS

Retrievable filters are associated with risks such as damaging veins and failing to stop blood clots from bypassing the device. Serious complications can occur because of these filters like when a device breaks apart, for instance, and travels to another area of the body - otherwise known as device migration. This is the most common adverse reaction. Embolization, listed by the Federal Drug Administration (FDA), is the second most frequently reported complication.

Retrievable IVC filters are for short-term placement only, and the FDA reported concern about the devices staying in patients long after PE risks subsided. The FDA updated safety communication in 2014, recommending retrievable devices be removed between the 29th and 54th day after implantation in patients in which PE subsided.

SIDE EFFECTS

Former recipients of retrievable IVC filters filed legal claims against manufacturers for poor design, manufacturing and failing to warn of risks.

Faulty filters have punctured veins and fractured and migrated to other parts of the body causing potentially lethal complications. In a report released in 2010, the FDA received more than 900 reports of adverse events associated with IVC filters, including 70 filter perforations, 328 device migrations, 56 filter fractures, and 146 embolisms.

HOW BERNSTEIN, DECAILLY & MARSHALL, PLLC CAN HELP

Studies have revealed five retrievable IVC filters prone to failure – Bard’s Recovery, Bard’s G2, Bard’s G2 Express, Cook’s Gunther Tulip and Cook’s Celect. Studies have revealed five retrievable IVC filters prone to failure – Bard’s Recovery, Bard’s G2, Bard’s G2 Express, Cook’s Gunther Tulip and Cook’s Celect. If you or someone you know has received any of these IVC filters and experienced any adverse side effects, you should seek legal counsel immediately.

IVC Filter

fracture, migration, perforation, hemorrhage or tilting
IVC Filter

ABOUT THE DEVICE

Retrievable inferior vena cava filters also known as IVC filters are small, metal devices that are designed to stop blood clots from traveling to the lungs. The device resembles a metal cage. It must be surgically inserted into a patient’s vein by a medical professional. Though most patients take blood thinners to stop blood clots, doctors use IVCs on patients who cannot – for whatever reason - use blood thinners.

The device was introduced in 1979, and its use increased through the years. By 2012, doctors inserted over 259,000 IVC filters in patients.

PURPOSE OF THE DEVICE

The inferior vena cava is the largest vein in the body, moving deoxygenated blood from the lower legs to the heart and then the lungs. In order to prevent life-threatening pulmonary embolisms (PEs), blood clots from traveling through the vein into the lungs, doctors implant an IVC filter in the vein. Retrievable filters are associated with potential risks, like damaging veins and failing to stop blood clots from bypassing the device.

A doctor will insert the device into a patient’s inferior vena cava using a catheter via a small incision in the neck or groin. The device’s metal wires then capture and trap blood clots before they can reach the lungs.

Some filters are permanent, and some are retrievable or temporary. Doctors remove retrievable filters in a similar way as they implant them. Healthcare providers inject contrast or X-ray dye around the device to make sure it is safe to proceed with the removal. A catheter-like snare goes into the vein and grabs the hook located at the end of the filter. The filter is then covered by a sheath and pulled out of the vein.

WARNINGS

Retrievable filters are associated with risks such as damaging veins and failing to stop blood clots from bypassing the device. Serious complications can occur because of these filters like when a device breaks apart, for instance, and travels to another area of the body - otherwise known as device migration. This is the most common adverse reaction. Embolization, listed by the Federal Drug Administration (FDA), is the second most frequently reported complication.

Retrievable IVC filters are for short-term placement only, and the FDA reported concern about the devices staying in patients long after PE risks subsided. The FDA updated safety communication in 2014, recommending retrievable devices be removed between the 29th and 54th day after implantation in patients in which PE subsided.

SIDE EFFECTS

Former recipients of retrievable IVC filters filed legal claims against manufacturers for poor design, manufacturing and failing to warn of risks.

Faulty filters have punctured veins and fractured and migrated to other parts of the body causing potentially lethal complications. In a report released in 2010, the FDA received more than 900 reports of adverse events associated with IVC filters, including 70 filter perforations, 328 device migrations, 56 filter fractures, and 146 embolisms.

HOW BERNSTEIN, DECAILLY & MARSHALL, PLLC CAN HELP

Studies have revealed five retrievable IVC filters prone to failure – Bard’s Recovery, Bard’s G2, Bard’s G2 Express, Cook’s Gunther Tulip and Cook’s Celect. Studies have revealed five retrievable IVC filters prone to failure – Bard’s Recovery, Bard’s G2, Bard’s G2 Express, Cook’s Gunther Tulip and Cook’s Celect. If you or someone you know has received any of these IVC filters and experienced any adverse side effects, you should seek legal counsel immediately.

There is no fee unless you are awarded compensation

(844) 875-4747